Jessie R Chung1, Brendan Flannery1, Manjusha Gaglani2,3, Michael E Smith3, Evelyn C Reis4, Robert W Hickey5, Michael L Jackson6, Lisa A Jackson6, Edward A Belongia7, Huong Q McLean7, Emily T Martin8, Hannah E Segaloff8, Sara S Kim1, Manish M Patel1. 1. Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Texas A&M University Health Science Center College of Medicine, Temple. 3. Baylor Scott & White Health Research Institute, Temple, Texas. 4. Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 5. Department of Pediatric Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 6. Kaiser Permanente Washington Health Research Institute, Seattle, Washington. 7. Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin. 8. Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor.
Abstract
Importance: The burden of influenza among young children is high, and influenza vaccination is the primary strategy to prevent the virus and its complications. Less is known about differences in clinical protection following 1 vs 2 doses of initial influenza vaccination. Objectives: To describe patterns of influenza vaccination among young children who receive outpatient care for acute respiratory tract illness in the US and compare vaccine effectiveness (VE) against medically attended laboratory-confirmed influenza by number of influenza vaccine doses received. Design: This test-negative case-control study was conducted in outpatient clinics, including emergency departments, at 5 sites of the US Influenza Vaccine Effectiveness Network during the 2014-2015 through 2017-2018 influenza seasons. The present study was performed from November 5, 2014, to April 12, 2018, during periods of local influenza circulation. Children aged 6 months to 8 years with an acute respiratory tract illness with cough who presented for outpatient care within 7 days of illness onset were included. All children were tested using real-time, reverse-transcriptase polymerase chain reaction for influenza for research purposes. Exposures: Vaccination in the enrollment season with either 1 or 2 doses of inactivated influenza vaccine as documented from electronic medical records, including state immunization information systems. Main Outcomes and Measures: Medically attended acute respiratory tract infection with real-time, reverse-transcriptase polymerase chain reaction testing for influenza. Results: Of 7533 children, 3480 children (46%) were girls, 4687 children (62%) were non-Hispanic white, and 4871 children (65%) were younger than 5 years. A total of 3912 children (52%) were unvaccinated in the enrollment season, 2924 children (39%) were fully vaccinated, and 697 children (9%) were partially vaccinated. Adjusted VE against any influenza was 51% (95% CI, 44%-57%) among fully vaccinated children and 41% (95% CI, 25%-54%) among partially vaccinated children. Among 1519 vaccine-naive children aged 6 months to 2 years, the VE of 2 doses in the enrollment season was 53% (95% CI, 28%-70%), and the VE of 1 dose was 23% (95% CI, -11% to 47%); those who received 2 doses were less likely to test positive for influenza compared with children who received only 1 dose (adjusted odds ratio, 0.57; 95% CI, 0.35-0.93). Conclusions and Relevance: Consistent with US influenza vaccine policy, receipt of the recommended number of doses resulted in higher VE than partial vaccination in 4 influenza seasons. Efforts to improve 2-dose coverage for previously unvaccinated children may reduce the burden of influenza in this population.
Importance: The burden of influenza among young children is high, and influenza vaccination is the primary strategy to prevent the virus and its complications. Less is known about differences in clinical protection following 1 vs 2 doses of initial influenza vaccination. Objectives: To describe patterns of influenza vaccination among young children who receive outpatient care for acute respiratory tract illness in the US and compare vaccine effectiveness (VE) against medically attended laboratory-confirmed influenza by number of influenza vaccine doses received. Design: This test-negative case-control study was conducted in outpatient clinics, including emergency departments, at 5 sites of the US Influenza Vaccine Effectiveness Network during the 2014-2015 through 2017-2018 influenza seasons. The present study was performed from November 5, 2014, to April 12, 2018, during periods of local influenza circulation. Children aged 6 months to 8 years with an acute respiratory tract illness with cough who presented for outpatient care within 7 days of illness onset were included. All children were tested using real-time, reverse-transcriptase polymerase chain reaction for influenza for research purposes. Exposures: Vaccination in the enrollment season with either 1 or 2 doses of inactivated influenza vaccine as documented from electronic medical records, including state immunization information systems. Main Outcomes and Measures: Medically attended acute respiratory tract infection with real-time, reverse-transcriptase polymerase chain reaction testing for influenza. Results: Of 7533 children, 3480 children (46%) were girls, 4687 children (62%) were non-Hispanic white, and 4871 children (65%) were younger than 5 years. A total of 3912 children (52%) were unvaccinated in the enrollment season, 2924 children (39%) were fully vaccinated, and 697 children (9%) were partially vaccinated. Adjusted VE against any influenza was 51% (95% CI, 44%-57%) among fully vaccinated children and 41% (95% CI, 25%-54%) among partially vaccinated children. Among 1519 vaccine-naive children aged 6 months to 2 years, the VE of 2 doses in the enrollment season was 53% (95% CI, 28%-70%), and the VE of 1 dose was 23% (95% CI, -11% to 47%); those who received 2 doses were less likely to test positive for influenza compared with children who received only 1 dose (adjusted odds ratio, 0.57; 95% CI, 0.35-0.93). Conclusions and Relevance: Consistent with US influenza vaccine policy, receipt of the recommended number of doses resulted in higher VE than partial vaccination in 4 influenza seasons. Efforts to improve 2-dose coverage for previously unvaccinated children may reduce the burden of influenza in this population.
Authors: Kathleen M Neuzil; Lisa A Jackson; Jennifer Nelson; Alexander Klimov; Nancy Cox; Carolyn B Bridges; John Dunn; Frank DeStefano; David Shay Journal: J Infect Dis Date: 2006-09-11 Impact factor: 5.226
Authors: Jill M Ferdinands; Lauren E W Olsho; Anna A Agan; Niranjan Bhat; Ryan M Sullivan; Mark Hall; Peter M Mourani; Mark Thompson; Adrienne G Randolph Journal: J Infect Dis Date: 2014-03-26 Impact factor: 5.226
Authors: Huiying Chua; Susan S Chiu; Eunice L Y Chan; Shuo Feng; Mike Y W Kwan; Joshua S C Wong; J S Malik Peiris; Benjamin J Cowling Journal: J Infect Dis Date: 2019-10-08 Impact factor: 5.226
Authors: Emmanuel B Walter; Kathleen M Neuzil; Yuwei Zhu; Mary P Fairchok; Martha E Gagliano; Arnold S Monto; Janet A Englund Journal: Pediatrics Date: 2006-09 Impact factor: 7.124
Authors: Mandy A Allison; Matthew F Daley; Lori A Crane; Jennifer Barrow; Brenda L Beaty; Norma Allred; Stephen Berman; Allison Kempe Journal: J Pediatr Date: 2006-12 Impact factor: 4.406
Authors: Lisa A Grohskopf; Leslie Z Sokolow; Karen R Broder; Sonja J Olsen; Ruth A Karron; Daniel B Jernigan; Joseph S Bresee Journal: MMWR Recomm Rep Date: 2016-08-26
Authors: Mark G Thompson; Jessie Clippard; Joshua G Petrie; Michael L Jackson; Huong Q McLean; Manjusha Gaglani; Evelyn C Reis; Brendan Flannery; Arnold S Monto; Lisa Jackson; Edward A Belongia; Kempapura Murthy; Richard K Zimmerman; Swathi Thaker; Alicia M Fry Journal: Pediatr Infect Dis J Date: 2016-03 Impact factor: 2.129
Authors: Inci Yildirim; Carol M Kao; Ashley Tippett; Piyarat Suntarattiwong; Mohamed Munye; Jumi Yi; Mohnd Elmontser; Elizabeth Quincer; Chris Focht; Nora Watson; Hande Bilen; Julia M Baker; Ben Lopman; Elena Hogenesch; Christina A Rostad; Evan J Anderson Journal: Clin Infect Dis Date: 2021-11-16 Impact factor: 20.999
Authors: N Kronfeld-Schor; T J Stevenson; S Nickbakhsh; E S Schernhammer; X C Dopico; T Dayan; M Martinez; B Helm Journal: J Biol Rhythms Date: 2021-01-24 Impact factor: 3.182